Phathom Pharmaceuticals (PHAT) Accumulated Depreciation & Amortization (2022 - 2024)
Historic Accumulated Depreciation & Amortization for Phathom Pharmaceuticals (PHAT) over the last 3 years, with Q4 2024 value amounting to $800000.0.
- Phathom Pharmaceuticals' Accumulated Depreciation & Amortization rose 3333.33% to $800000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $800000.0, marking a year-over-year increase of 3333.33%. This contributed to the annual value of $800000.0 for FY2024, which is 3333.33% up from last year.
- Phathom Pharmaceuticals' Accumulated Depreciation & Amortization amounted to $800000.0 in Q4 2024, which was up 3333.33% from $200000.0 recorded in Q3 2024.
- Phathom Pharmaceuticals' Accumulated Depreciation & Amortization's 5-year high stood at $1.3 million during Q3 2022, with a 5-year trough of $100000.0 in Q1 2023.
- For the 3-year period, Phathom Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $526083.3, with its median value being $400000.0 (2022).
- As far as peak fluctuations go, Phathom Pharmaceuticals' Accumulated Depreciation & Amortization tumbled by 9233.13% in 2023, and later surged by 10000.0% in 2024.
- Over the past 3 years, Phathom Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $600000.0 in 2022, then changed by 0.0% to $600000.0 in 2023, then surged by 33.33% to $800000.0 in 2024.
- Its Accumulated Depreciation & Amortization was $800000.0 in Q4 2024, compared to $200000.0 in Q3 2024 and $200000.0 in Q2 2024.